Exane Derivatives’s Levi Strauss LEVI Stock Holding History

Exane Derivatives’s Portfolio LEVI Stock Details LEVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$29.8K	Sell	1,826 -7,246	-80%	-$131K	0.02%	345
2022 Q1	$179K	Sell	9,072 -1,173	-11%	-$25.3K	0.05%	362
2021 Q4	$256K	Buy	10,245 +8,766	+593%	+$226K	0.06%	293
2021 Q3	$36.2K	Hold	1,479	–	–	0.01%	649
2021 Q2	$42.4K	Buy	+1,479	New	+$40.7K	0.01%	657

Other funds holding LEVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cambridge Trust Cambridge, Massachusetts $2.64B AUM 28.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KAH

Kathryn A. Hall $186M AUM 12.55% 1-Year Est. Return

Exane Derivatives's LEVI Position: Q2 2022 in Review

Exane Derivatives reduced its Levi Strauss (LEVI) stake by 80% in Q2 2022, selling an estimated $131K and leaving 1,826 shares worth $29.8K. The position accounts for 0.02% of the portfolio, ranked #345.

Exane Derivatives first reported a position in LEVI in Q2 2021 and has held it in 5 quarters since. The position peaked at $256K in Q4 2021. 231 funds tracked by Wall St. Rank hold LEVI as of Q2 2022.

Exane Derivatives held 1,826 shares of Levi Strauss worth $29.8K as of Q2 2022.
Exane Derivatives sold 7,246 Levi Strauss shares in Q2 2022, an estimated $131K.
Levi Strauss made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #345 holding.
Exane Derivatives first reported a position in Levi Strauss in Q2 2021 and has held it in 5 quarters since.
Exane Derivatives's Levi Strauss position peaked at $256K in Q4 2021.
231 funds tracked by Wall St. Rank held Levi Strauss as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.